• AstraZeneca, Sileri: "It is possible that Ema limits use for certain categories"

  • Mannucci (Aifa) to Rainews24: AstraZeneca, very rare side effect likely to be included

  • Vaccines: used 54% doses Astrazeneca, 50% Moderna, 96% Pfizer

  • The Netherlands suspends AstraZeneca to avoid wasting doses after a stop at under 60

  • Canada suspends AstraZeneca vaccine for population under 55

Share

06 April 2021 AstraZeneca has announced a suspension of the ongoing trial for the administration of its anti-Covid vaccine to children and adolescents pending the British regulatory body to verify the possible link with cases of thrombosis in adults.



Professor Andrew Pollard of the University of Oxford told the BBC that there are no safety concerns with the test itself, but his scientists were awaiting further information.  



Kyriakides: Ema evaluation on Astrazneca tomorrow evening Ema

evaluation of AstraZeneca's anti-Covid vaccine is "scheduled for tomorrow evening". The EU Commissioner for Health, Stella Kyriakides, announced on Twitter.